Krystal Biotech Inc

Stock Chart, Company Information, and Scan Results

$156.98(as of Aug 1, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Krystal Biotech Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$156.98
Ticker SymbolKRYS
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees275
CountyUSA
Market Cap$4,446.6M
EBIDTA135.9M
10-Day Moving Average151.99
P/E Ratio37.83
20-Day Moving Average149.78
Forward P/E Ratio25.06
50-Day Moving Average140.35
Earnings per Share4.17
200-Day Moving Average161.93
Profit Margin40.52%
RSI64.88
Shares Outstanding28.9M
ATR4.98
52-Week High207.84
Volume566,304
52-Week Low122.80
Most Recent Support Level151.00
Book Value984.7M
Most Recent Resistance Level154.99
P/B Ratio4.76
Upper Keltner160.99
P/S Ratio14.06
Lower Keltner138.58
Debt-to-Equity Ratio160.99
Next Earnings Date08/04/2025
Cash Surplus229.3M
Next Ex-Dividend DateUnknown

Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States. The company commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). It also develops KB105, which is in Phase 1/2 clinical trials for treating patients with deficient autosomal recessive congenital ichthyosis; KB104 for treating netherton syndrome; KB407 that is in Phase 1 clinical trials for treating cystic fibrosis; KB707 that is in Phase 1/2 clinical trials for the treatment of anti-PD-1 relapsed/refractory; KB408, which is in Phase 1 clinical trials for treating Alpha-1 antitrypsin deficiency; and KB301 that is in Phase 2 clinical trials for treating aesthetic skin conditions, as well as in open label study with ophthalmic B-VEC for treating for ocular complications of deb. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.

Krystal Biotech Inc In Our Stock Scanner

As of Aug 01, 2025
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Uptrending StocksScan Type: Chart Pattern Scans
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.